Repligen Releases Inaugural Sustainability Report
November 05, 2021 07:30 ET
|
Repligen Corporation
WALTHAM, Mass., Nov. 05, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN) today released its inaugural sustainability report, available on the Company’s website. Repligen’s 2020...
Repligen Reports Third Quarter 2021 Financial Results and Updates Full Year 2021 Financial Guidance
October 28, 2021 07:30 ET
|
Repligen Corporation
Reports record revenue of $178.2 million for the quarter, representing year-over-year growth of 89% and organic growth of 77%Raises revenue guidance to $655-$665 million for full year 2021Completes...
Repligen to Report Third Quarter 2021 Financial Results
October 14, 2021 07:30 ET
|
Repligen Corporation
Webcast and Conference Call to Be Held Thursday, October 28, 2021 at 8:30 a.m. EDT WALTHAM, Mass., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the...
Repligen Announces Agreement to Acquire Avitide Inc.
September 16, 2021 07:40 ET
|
Repligen Corporation
Proposed acquisition strengthens Repligen’s Proteins business Adds a market leader in affinity ligand discovery and development and complements established partnership with Navigo GmbH Strategically...
Repligen and Navigo GmbH Announce Launch of Industry-First Protein A Ligand for Purification of pH Sensitive Antibodies
September 09, 2021 07:30 ET
|
Repligen Corporation
WALTHAM, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, and Navigo Proteins GmbH (“Navigo”),...
Repligen Reports Second Quarter 2021 Financial Results and Updates Full Year 2021 Financial Guidance
July 27, 2021 07:30 ET
|
Repligen Corporation
Reported revenue was $163.0 million for the quarter, representing year-over-year growth of 86% and organic growth of 69%Revenue guidance raised to $625-$645 million for full year 2021Acquisition of...
Repligen to Report Second Quarter 2021 Financial Results
July 13, 2021 07:30 ET
|
Repligen Corporation
WALTHAM, Mass., July 13, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its second quarter 2021 financial results on Tuesday, July 27, 2021....
Repligen Corporation Announces Agreement to Acquire Polymem S.A.
June 22, 2021 06:30 ET
|
Repligen Corporation
WALTHAM, Mass., June 22, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has entered into...
Repligen Corporation to Present at Upcoming Investor Conferences
May 25, 2021 07:30 ET
|
Repligen Corporation
WALTHAM, Mass., May 25, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present...
Repligen Reports First Quarter 2021 Financial Results and Updates Full Year 2021 Financial Guidance
May 04, 2021 07:30 ET
|
Repligen Corporation
Reported revenue was $142.8 million for the quarter, representing year-over-year growth of 88% and organic growth of 69%Growth driven by combination of COVID-related demand, base business strength and...